CRISPR Therapeutics Insider Trades
NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $119.48K
- Shares bought / sold
- 0 / 1.99K
- Net activity
- Net selling $119,481
CRISPR Therapeutics insider activity
Over the last 12 months, CRISPR Therapeutics insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $119,481 worth of stock, for net insider selling of $119,481. The largest seller was KASINGER JAMES R., with $119,481 in reported sales.
The most recent filing shows KASINGER JAMES R. (General Counsel and Secretary) reporting a transaction in 1,990 shares at $13.62 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CRSP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CRSP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | KASINGER JAMES R.General Counsel and Secretary | Sale | 1,990 | $119.48K | Form 4 |
| Oct 6, 2026 | KASINGER JAMES R.General Counsel and Secretary | Option exercise | 1,990 | $27.10K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4